Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 85
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 40
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

703 Results (Page 20 of 36)
- Relevance
  Sort by

Retinal Drugs Market 2025-2029

 Report
April 2025
217 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1756EUR$1,997USD£1,513GBP

Skeletal Dysplasia - Global Strategic Business Report

 Report
July 2025
378 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Peanut Allergy - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1319EUR$1,500USD£1,136GBP

Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive and Consultant Guides

 Report
July 2025
835 Pages
Global

From

€6150EUR$6,995USD£5,299GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
62 Pages
Global

From

€1758EUR$2,000USD£1,515GBP

Whole Genome and Exome Sequencing Market: By Application, Organism and Product with Executive and Consultant Guides

 Report
July 2025
681 Pages
Global

From

€6150EUR$6,995USD£5,299GBP

Age-related Macular Degeneration Market by Route Of Administration, Treatment, Drug Class, Type, End User, Distribution Channel, Stage - Global Forecast to 2030

 Report
May 2025
192 Pages
Global

From

€3117EUR$3,545USD£2,686GBP

€3463EUR$3,939USD£2,984GBP

Ophthalmic Drugs Market by Product Type, Drug Class, Dosage Form, Route of Administration, Therapeutic Area, Patient Demographics, End User - Global Forecast to 2030

 Report
May 2025
184 Pages
Global

From

€3117EUR$3,545USD£2,686GBP

€3463EUR$3,939USD£2,984GBP

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

 Report
November 2024
716 Pages
Global

From

€4219EUR$4,799USD£3,636GBP

Lysosomal Acid Lipase Deficiency Treatment - Global Strategic Business Report

 Report
July 2025
279 Pages
Global

From

€5143EUR$5,850USD£4,432GBP

Heterozygous familial hypercholesterolemia (heFH) Disease - Global Clinical Trials Review, H1, 2021

 Clinical Trials
February 2021
263 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
July 2025
262 Pages
Global

From

€6150EUR$6,995USD£5,299GBP

Pulmonary Embolism Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3948EUR$4,490USD£3,402GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3512EUR$3,995USD£3,027GBP

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

 Report
February 2025
222 Pages
Global

From

€2198EUR$2,500USD£1,894GBP

Asthma Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
January 2025
105 Pages
Global

From

€3500EUR$4,264USD£3,121GBP

Viral Vector Collaboration and Licensing Deals 2016-2025

 Report
May 2025
250 Pages
Global

From

€3512EUR$3,995USD£3,027GBP

Metastatic Colorectal Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
88 Pages
Global

From

€3500EUR$4,264USD£3,121GBP

703 Results (Page 20 of 36)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.